760 Trough levels of ipilimumab in serum as a potential predictive biomarker of clinical outcomes for patients with advanced melanoma after treatment with ipilimumab

760 Trough levels of ipilimumab in serum as a potential predictive biomarker of clinical outcomes for patients with advanced melanoma after treatment with ipilimumab

Bibliographic Details
Main Authors: William Redmond, Brendan Curti, John Cha, Walter Urba, Yoshinobu Koguchi, Brian Piening, Noriko Iwamoto, Takashi Shimada, Shu-Ching Chang
Format: Article
Language:English
Published: BMJ Publishing Group 2020-11-01
Series:Journal for ImmunoTherapy of Cancer
id doaj-62169d391ea044b983cb58593bcc3ef6
record_format Article
spelling doaj-62169d391ea044b983cb58593bcc3ef62020-12-11T10:03:55ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262020-11-018Suppl 310.1136/jitc-2020-SITC2020.0760760 Trough levels of ipilimumab in serum as a potential predictive biomarker of clinical outcomes for patients with advanced melanoma after treatment with ipilimumabWilliam Redmond0Brendan Curti1John Cha2Walter Urba3Yoshinobu Koguchi4Brian Piening5Noriko Iwamoto6Takashi Shimada7Shu-Ching Chang81Earle A. Chiles Research Institute, Portland, OR, USA1 Providence Cancer Institute, Earle A Chiles Research Institute, Providence Portland Medical Center, Portland, Oregon, USA 1Providence Cancer Institute, Portland, OR, USA1Providence Cancer Institute, Portland, OR, USA1Providence Cancer Institute, Portland, OR, USA1Providence Cancer Institute, Portland, OR, USA2Shimadzu Scientific Instruments, Bothell, WA, USA2Shimadzu Scientific Instruments, Bothell, WA, USA3Providence St. Joseph Health, Portland, OR, USA
collection DOAJ
language English
format Article
sources DOAJ
author William Redmond
Brendan Curti
John Cha
Walter Urba
Yoshinobu Koguchi
Brian Piening
Noriko Iwamoto
Takashi Shimada
Shu-Ching Chang
spellingShingle William Redmond
Brendan Curti
John Cha
Walter Urba
Yoshinobu Koguchi
Brian Piening
Noriko Iwamoto
Takashi Shimada
Shu-Ching Chang
760 Trough levels of ipilimumab in serum as a potential predictive biomarker of clinical outcomes for patients with advanced melanoma after treatment with ipilimumab
Journal for ImmunoTherapy of Cancer
author_facet William Redmond
Brendan Curti
John Cha
Walter Urba
Yoshinobu Koguchi
Brian Piening
Noriko Iwamoto
Takashi Shimada
Shu-Ching Chang
author_sort William Redmond
title 760 Trough levels of ipilimumab in serum as a potential predictive biomarker of clinical outcomes for patients with advanced melanoma after treatment with ipilimumab
title_short 760 Trough levels of ipilimumab in serum as a potential predictive biomarker of clinical outcomes for patients with advanced melanoma after treatment with ipilimumab
title_full 760 Trough levels of ipilimumab in serum as a potential predictive biomarker of clinical outcomes for patients with advanced melanoma after treatment with ipilimumab
title_fullStr 760 Trough levels of ipilimumab in serum as a potential predictive biomarker of clinical outcomes for patients with advanced melanoma after treatment with ipilimumab
title_full_unstemmed 760 Trough levels of ipilimumab in serum as a potential predictive biomarker of clinical outcomes for patients with advanced melanoma after treatment with ipilimumab
title_sort 760 trough levels of ipilimumab in serum as a potential predictive biomarker of clinical outcomes for patients with advanced melanoma after treatment with ipilimumab
publisher BMJ Publishing Group
series Journal for ImmunoTherapy of Cancer
issn 2051-1426
publishDate 2020-11-01
work_keys_str_mv AT williamredmond 760troughlevelsofipilimumabinserumasapotentialpredictivebiomarkerofclinicaloutcomesforpatientswithadvancedmelanomaaftertreatmentwithipilimumab
AT brendancurti 760troughlevelsofipilimumabinserumasapotentialpredictivebiomarkerofclinicaloutcomesforpatientswithadvancedmelanomaaftertreatmentwithipilimumab
AT johncha 760troughlevelsofipilimumabinserumasapotentialpredictivebiomarkerofclinicaloutcomesforpatientswithadvancedmelanomaaftertreatmentwithipilimumab
AT walterurba 760troughlevelsofipilimumabinserumasapotentialpredictivebiomarkerofclinicaloutcomesforpatientswithadvancedmelanomaaftertreatmentwithipilimumab
AT yoshinobukoguchi 760troughlevelsofipilimumabinserumasapotentialpredictivebiomarkerofclinicaloutcomesforpatientswithadvancedmelanomaaftertreatmentwithipilimumab
AT brianpiening 760troughlevelsofipilimumabinserumasapotentialpredictivebiomarkerofclinicaloutcomesforpatientswithadvancedmelanomaaftertreatmentwithipilimumab
AT norikoiwamoto 760troughlevelsofipilimumabinserumasapotentialpredictivebiomarkerofclinicaloutcomesforpatientswithadvancedmelanomaaftertreatmentwithipilimumab
AT takashishimada 760troughlevelsofipilimumabinserumasapotentialpredictivebiomarkerofclinicaloutcomesforpatientswithadvancedmelanomaaftertreatmentwithipilimumab
AT shuchingchang 760troughlevelsofipilimumabinserumasapotentialpredictivebiomarkerofclinicaloutcomesforpatientswithadvancedmelanomaaftertreatmentwithipilimumab
_version_ 1724386453169897472

Similar Items